Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients

D. J. Kilmartin, D. W. Wilson, Janet Mary Liversidge, A. D. Dick, J. Bruce, R. W. Acheson, Stanislaw Urbaniak, John Vincent Forrester

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background/aims-Sympathetic ophthalmia (SO) is a classic example of autoimmune disease where human leucocyte antigen (HLA) genomic associations could provide further understanding of mechanisms of disease. This study sought to assess HLA genetic polymorphism in British and Irish patients with SO, and to assess whether HLA gene variants are associated with clinical phenotype or disease severity.

Methods-High resolution DNA based HLA typing using polymerase chain reaction sequence specific primers was performed in 27 patients with SO and 51 matched healthy controls. Clinical phenotype and markers of disease severity were determined prospectively in 17 newly diagnosed patients and from medical record review and repeat clinical examination in 10 previously diagnosed patients.

Results-HLA-Cw*03 (p=0.008), DRB1*04 (p=0.017), and DQA1*03 (p=0.014) were significantly associated with SO. For class IT alleles at higher resolution, only HLA-DRBl*0404 (relative risk (RR) = 5.6, p = 0.045) was significantly associated with SO. The highest relative risk for any of the associated haplotypes was with HLA-DRB1*0404-DQA1*0301 (RR=10.9, p = 0.019). Patients with the DRB1*04-DQA1*03 associated haplotype were significantly more Likely to develop SO earlier, with fewer inciting ocular trauma events, and to require more systemic steroid therapy to control inflammatory activity.

Conclusions-Sympathetic ophthalmia is associated with HLA-DRB1*04 and DQA1*03 genotypes in white patients, similar to Japanese patients. Differences in DRB1*04 gene variant associations (-0404 in Britain and Ireland and -0405 in Japan) may have implications for HLA peptide binding in disease initiation. The DRB1*04-DQA1*03 haplotype is a marker of increased SO susceptibility and severity, as in Vogt-Koyanagi-Harada disease, which also has similar clinicopathological and HLA associations.

Original languageEnglish
Pages (from-to)281-286
Number of pages5
JournalBritish Journal of Ophthalmology
Volume85
Issue number3
DOIs
Publication statusPublished - 2001

Keywords

  • KOYANAGI-HARADA DISEASE
  • RHEUMATOID-ARTHRITIS
  • T-CELLS
  • HLA
  • ASSOCIATION
  • UVEITIS
  • GENES
  • GAMMA

Cite this

Kilmartin, D. J., Wilson, D. W., Liversidge, J. M., Dick, A. D., Bruce, J., Acheson, R. W., ... Forrester, J. V. (2001). Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. British Journal of Ophthalmology, 85(3), 281-286. https://doi.org/10.1136/bjo.85.3.281

Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. / Kilmartin, D. J.; Wilson, D. W.; Liversidge, Janet Mary; Dick, A. D.; Bruce, J.; Acheson, R. W.; Urbaniak, Stanislaw; Forrester, John Vincent.

In: British Journal of Ophthalmology, Vol. 85, No. 3, 2001, p. 281-286.

Research output: Contribution to journalArticle

Kilmartin, DJ, Wilson, DW, Liversidge, JM, Dick, AD, Bruce, J, Acheson, RW, Urbaniak, S & Forrester, JV 2001, 'Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients', British Journal of Ophthalmology, vol. 85, no. 3, pp. 281-286. https://doi.org/10.1136/bjo.85.3.281
Kilmartin, D. J. ; Wilson, D. W. ; Liversidge, Janet Mary ; Dick, A. D. ; Bruce, J. ; Acheson, R. W. ; Urbaniak, Stanislaw ; Forrester, John Vincent. / Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. In: British Journal of Ophthalmology. 2001 ; Vol. 85, No. 3. pp. 281-286.
@article{4f748a7d11dc4cbba3c74826f837d4b1,
title = "Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients",
abstract = "Background/aims-Sympathetic ophthalmia (SO) is a classic example of autoimmune disease where human leucocyte antigen (HLA) genomic associations could provide further understanding of mechanisms of disease. This study sought to assess HLA genetic polymorphism in British and Irish patients with SO, and to assess whether HLA gene variants are associated with clinical phenotype or disease severity.Methods-High resolution DNA based HLA typing using polymerase chain reaction sequence specific primers was performed in 27 patients with SO and 51 matched healthy controls. Clinical phenotype and markers of disease severity were determined prospectively in 17 newly diagnosed patients and from medical record review and repeat clinical examination in 10 previously diagnosed patients.Results-HLA-Cw*03 (p=0.008), DRB1*04 (p=0.017), and DQA1*03 (p=0.014) were significantly associated with SO. For class IT alleles at higher resolution, only HLA-DRBl*0404 (relative risk (RR) = 5.6, p = 0.045) was significantly associated with SO. The highest relative risk for any of the associated haplotypes was with HLA-DRB1*0404-DQA1*0301 (RR=10.9, p = 0.019). Patients with the DRB1*04-DQA1*03 associated haplotype were significantly more Likely to develop SO earlier, with fewer inciting ocular trauma events, and to require more systemic steroid therapy to control inflammatory activity.Conclusions-Sympathetic ophthalmia is associated with HLA-DRB1*04 and DQA1*03 genotypes in white patients, similar to Japanese patients. Differences in DRB1*04 gene variant associations (-0404 in Britain and Ireland and -0405 in Japan) may have implications for HLA peptide binding in disease initiation. The DRB1*04-DQA1*03 haplotype is a marker of increased SO susceptibility and severity, as in Vogt-Koyanagi-Harada disease, which also has similar clinicopathological and HLA associations.",
keywords = "KOYANAGI-HARADA DISEASE, RHEUMATOID-ARTHRITIS, T-CELLS, HLA, ASSOCIATION, UVEITIS, GENES, GAMMA",
author = "Kilmartin, {D. J.} and Wilson, {D. W.} and Liversidge, {Janet Mary} and Dick, {A. D.} and J. Bruce and Acheson, {R. W.} and Stanislaw Urbaniak and Forrester, {John Vincent}",
year = "2001",
doi = "10.1136/bjo.85.3.281",
language = "English",
volume = "85",
pages = "281--286",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients

AU - Kilmartin, D. J.

AU - Wilson, D. W.

AU - Liversidge, Janet Mary

AU - Dick, A. D.

AU - Bruce, J.

AU - Acheson, R. W.

AU - Urbaniak, Stanislaw

AU - Forrester, John Vincent

PY - 2001

Y1 - 2001

N2 - Background/aims-Sympathetic ophthalmia (SO) is a classic example of autoimmune disease where human leucocyte antigen (HLA) genomic associations could provide further understanding of mechanisms of disease. This study sought to assess HLA genetic polymorphism in British and Irish patients with SO, and to assess whether HLA gene variants are associated with clinical phenotype or disease severity.Methods-High resolution DNA based HLA typing using polymerase chain reaction sequence specific primers was performed in 27 patients with SO and 51 matched healthy controls. Clinical phenotype and markers of disease severity were determined prospectively in 17 newly diagnosed patients and from medical record review and repeat clinical examination in 10 previously diagnosed patients.Results-HLA-Cw*03 (p=0.008), DRB1*04 (p=0.017), and DQA1*03 (p=0.014) were significantly associated with SO. For class IT alleles at higher resolution, only HLA-DRBl*0404 (relative risk (RR) = 5.6, p = 0.045) was significantly associated with SO. The highest relative risk for any of the associated haplotypes was with HLA-DRB1*0404-DQA1*0301 (RR=10.9, p = 0.019). Patients with the DRB1*04-DQA1*03 associated haplotype were significantly more Likely to develop SO earlier, with fewer inciting ocular trauma events, and to require more systemic steroid therapy to control inflammatory activity.Conclusions-Sympathetic ophthalmia is associated with HLA-DRB1*04 and DQA1*03 genotypes in white patients, similar to Japanese patients. Differences in DRB1*04 gene variant associations (-0404 in Britain and Ireland and -0405 in Japan) may have implications for HLA peptide binding in disease initiation. The DRB1*04-DQA1*03 haplotype is a marker of increased SO susceptibility and severity, as in Vogt-Koyanagi-Harada disease, which also has similar clinicopathological and HLA associations.

AB - Background/aims-Sympathetic ophthalmia (SO) is a classic example of autoimmune disease where human leucocyte antigen (HLA) genomic associations could provide further understanding of mechanisms of disease. This study sought to assess HLA genetic polymorphism in British and Irish patients with SO, and to assess whether HLA gene variants are associated with clinical phenotype or disease severity.Methods-High resolution DNA based HLA typing using polymerase chain reaction sequence specific primers was performed in 27 patients with SO and 51 matched healthy controls. Clinical phenotype and markers of disease severity were determined prospectively in 17 newly diagnosed patients and from medical record review and repeat clinical examination in 10 previously diagnosed patients.Results-HLA-Cw*03 (p=0.008), DRB1*04 (p=0.017), and DQA1*03 (p=0.014) were significantly associated with SO. For class IT alleles at higher resolution, only HLA-DRBl*0404 (relative risk (RR) = 5.6, p = 0.045) was significantly associated with SO. The highest relative risk for any of the associated haplotypes was with HLA-DRB1*0404-DQA1*0301 (RR=10.9, p = 0.019). Patients with the DRB1*04-DQA1*03 associated haplotype were significantly more Likely to develop SO earlier, with fewer inciting ocular trauma events, and to require more systemic steroid therapy to control inflammatory activity.Conclusions-Sympathetic ophthalmia is associated with HLA-DRB1*04 and DQA1*03 genotypes in white patients, similar to Japanese patients. Differences in DRB1*04 gene variant associations (-0404 in Britain and Ireland and -0405 in Japan) may have implications for HLA peptide binding in disease initiation. The DRB1*04-DQA1*03 haplotype is a marker of increased SO susceptibility and severity, as in Vogt-Koyanagi-Harada disease, which also has similar clinicopathological and HLA associations.

KW - KOYANAGI-HARADA DISEASE

KW - RHEUMATOID-ARTHRITIS

KW - T-CELLS

KW - HLA

KW - ASSOCIATION

KW - UVEITIS

KW - GENES

KW - GAMMA

U2 - 10.1136/bjo.85.3.281

DO - 10.1136/bjo.85.3.281

M3 - Article

VL - 85

SP - 281

EP - 286

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 3

ER -